Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126739212 | 12673921 | 2 | F | 20160704 | 20160914 | 20160822 | 20160923 | EXP | JP-ELI_LILLY_AND_COMPANY-JP201608007964 | ELI LILLY AND CO | 95.24 | YR | M | Y | 74.00000 | KG | 20160923 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126739212 | 12673921 | 1 | PS | Zalutia | TADALAFIL | 1 | Oral | 5 MG, QD | Y | 21368 | 5 | MG | TABLET | QD | |||||
| 126739212 | 12673921 | 2 | SS | Zalutia | TADALAFIL | 1 | Y | 21368 | TABLET | ||||||||||
| 126739212 | 12673921 | 3 | SS | AVOLVE | DUTASTERIDE | 1 | Oral | 0.5 MG, QD | Y | 0 | .5 | MG | QD | ||||||
| 126739212 | 12673921 | 4 | SS | LOXONIN | LOXOPROFEN SODIUM | 1 | Oral | 60 MG, QD | Y | 0 | 60 | MG | QD | ||||||
| 126739212 | 12673921 | 5 | SS | BETANIS | MIRABEGRON | 1 | Oral | 50 MG, QD | Y | 0 | 50 | MG | QD | ||||||
| 126739212 | 12673921 | 6 | C | URSO | URSODIOL | 1 | Oral | 200 MG, TID | 0 | 200 | MG | TID | |||||||
| 126739212 | 12673921 | 7 | C | VITAMINS NOS | VITAMINS | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID | |||||||
| 126739212 | 12673921 | 8 | C | LAC B | BIFIDOBACTERIUM SPP. | 1 | Oral | UNK | 0 | ||||||||||
| 126739212 | 12673921 | 9 | C | MUCOSTA | REBAMIPIDE | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126739212 | 12673921 | 1 | Benign prostatic hyperplasia |
| 126739212 | 12673921 | 2 | Dysuria |
| 126739212 | 12673921 | 3 | Benign prostatic hyperplasia |
| 126739212 | 12673921 | 4 | Pollakiuria |
| 126739212 | 12673921 | 5 | Pollakiuria |
| 126739212 | 12673921 | 6 | Bile duct stone |
| 126739212 | 12673921 | 7 | Spinal column stenosis |
| 126739212 | 12673921 | 8 | Product used for unknown indication |
| 126739212 | 12673921 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126739212 | 12673921 | OT |
| 126739212 | 12673921 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126739212 | 12673921 | Dyspnoea | |
| 126739212 | 12673921 | Eosinophil count increased | |
| 126739212 | 12673921 | Erythema | |
| 126739212 | 12673921 | Feeling hot | |
| 126739212 | 12673921 | Oedema | |
| 126739212 | 12673921 | Tenderness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126739212 | 12673921 | 1 | 20160708 | 0 | ||
| 126739212 | 12673921 | 3 | 20160708 | 0 | ||
| 126739212 | 12673921 | 4 | 20160708 | 0 | ||
| 126739212 | 12673921 | 5 | 20160708 | 0 |